Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Starmer says UK to recognize Palestinian state if...
‘Critical’ closed-door congressional huddle focuses on growing antisemitism...
Trump’s CDC pick confirmed—but her pro-vaccine stance may...
Trump pick Emil Bove confirmed as federal judge...
From Gaza to Greenland, Macron breaks with Trump...
Schumer calls on FBI to conduct counterintelligence threat...
Biden ‘Politburo’ member Steve Ricchetti to appear before...
Trump looks to skip G20 summit in South...
Backlash against Sydney Sweeney ‘jeans/genes’ ad gets mocked...
Biden ‘Politburo’ member Steve Ricchetti appears before House...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
Brian Leni: Latest Mining Stock Wins and How I’m Deploying Cash Now
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

FBI investigation of Trump assassination attempt involves ‘full...

September 18, 2024

Hunter Biden pardon raises new questions over 5th...

December 4, 2024

Obama-era officials mum on allegations of ‘manufactured’ intelligence...

July 22, 2025

Biden’s ‘decline’: GOP lawmakers question what Kamala knew...

July 25, 2024

Duffy blasts Buttigieg, accusing Biden-era official of ‘mismanagement’:...

February 18, 2025

The one characteristic of Reagan and Trump that...

July 28, 2024

Dem rep says she was ‘angry at first’...

July 24, 2024

New book details Obama’s strained relationship with Democratic...

April 5, 2025

Melania Trump to release ‘Collector’s Edition’ of memoir...

October 16, 2024

Israel’s Netanyahu delays Gaza cease-fire deal, accusing Hamas...

January 16, 2025

Recent Posts

  • Starmer says UK to recognize Palestinian state if Israel doesn’t agree to ceasefire, Hamas must ‘disarm’
  • ‘Critical’ closed-door congressional huddle focuses on growing antisemitism in US, Mamdani’s rise
  • Trump’s CDC pick confirmed—but her pro-vaccine stance may clash with RFK Jr.’s agenda
  • Trump pick Emil Bove confirmed as federal judge after furious Democrat walkout, whistleblower complaints
  • From Gaza to Greenland, Macron breaks with Trump on global flashpoints

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (845)
    • Investing (2,651)
    • Politics (3,267)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.